[HTML][HTML] Body fatness associations with cancer: evidence from recent epidemiological studies and future directions

SC Larsson, N Spyrou, CS Mantzoros - Metabolism, 2022 - Elsevier
This narrative review highlights current evidence linking greater body fatness to risk of
various cancers, with focus on evidence from recent large cohort studies and pooled …

From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century

M Blüher, CS Mantzoros - Metabolism, 2015 - Elsevier
This year marks the 20th anniversary of the discovery of leptin, which has tremendously
stimulated translational obesity research. The discovery of leptin has led to realizations that …

The role of adiponectin in cancer: a review of current evidence

M Dalamaga, KN Diakopoulos… - Endocrine …, 2012 - academic.oup.com
Improving physical function and mobility in a continuously expanding elderly population
emerges as a high priority of medicine today. Muscle mass, strength/power, and maximal …

Obesity and cancer: the role of dysfunctional adipose tissue

RCM Van Kruijsdijk, E Van Der Wall… - … , biomarkers & prevention, 2009 - AACR
Overweight and obesity are health problems of epidemic proportions, increasing the risk not
only of cardiovascular disease and type 2 diabetes mellitus but also of various types of …

Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets

SK Tan, HY Hougen, JR Merchan, ML Gonzalgo… - Nature Reviews …, 2023 - nature.com
Lipid droplet formation is a defining histological feature in clear-cell renal cell carcinoma
(ccRCC) but the underlying mechanisms and importance of this biological behaviour have …

Paracrine and endocrine effects of adipose tissue on cancer development and progression

J Park, DM Euhus, PE Scherer - Endocrine reviews, 2011 - academic.oup.com
The past few years have provided substantial evidence for the vital role of the local tumor
microenvironment for various aspects of tumor progression. With obesity and its …

[HTML][HTML] Adiponectin, driver or passenger on the road to insulin sensitivity?

R Ye, PE Scherer - Molecular metabolism, 2013 - Elsevier
Almost 20 years have passed since the first laboratory evidence emerged that an abundant
message encoding a protein with homology to the C1q superfamily is highly specifically …

Obesity and cancer: symposium on 'Diet and cancer'

T Pischon, U Nöthlings, H Boeing - Proceedings of the Nutrition …, 2008 - cambridge.org
The prevalence of obesity, defined as a BMI of≥ 30· 0 kg/m2, has increased substantially
over previous decades to about 20% in industrialized countries, and a further increase is …

Metabolic syndrome and risk of cancer: which link?

FM Mendonça, FR de Sousa, AL Barbosa, SC Martins… - Metabolism, 2015 - Elsevier
Metabolic syndrome (MS) is characterized by a group of metabolic disturbances which lead
to an enhanced risk of cardiovascular diseases and type 2 diabetes mellitus. MS constitutes …

[HTML][HTML] Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence

D Barb, CJ Williams, AK Neuwirth… - The American journal of …, 2007 - Elsevier
Adiponectin, an adipocyte-secreted hormone that plays an important role in diabetes and
cardiovascular disease, may also be of importance in the development and progression of …